Adam Maeder

Stock Analyst at Piper Sandler

(3.36)
# 2,150
Out of 5,040 analysts
95
Total ratings
43.75%
Success rate
6.32%
Average return

Stocks Rated by Adam Maeder

Intuitive Surgical
Oct 22, 2025
Reiterates: Overweight
Price Target: $595$610
Current: $551.30
Upside: +10.65%
Vicarious Surgical
Aug 13, 2025
Maintains: Neutral
Price Target: $8.5$7
Current: $5.98
Upside: +17.06%
Inspire Medical Systems
Aug 5, 2025
Maintains: Overweight
Price Target: $233$150
Current: $80.17
Upside: +87.10%
ResMed
Aug 1, 2025
Maintains: Neutral
Price Target: $248$270
Current: $265.26
Upside: +1.79%
Edwards Lifesciences
Jul 25, 2025
Maintains: Overweight
Price Target: $83$90
Current: $76.53
Upside: +17.60%
RxSight
Jul 9, 2025
Maintains: Neutral
Price Target: $18$10
Current: $8.43
Upside: +18.62%
Sight Sciences
Jun 18, 2025
Maintains: Neutral
Price Target: $3.5$4
Current: $5.21
Upside: -23.22%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5$4
Current: $2.25
Upside: +77.78%
Tactile Systems Technology
May 6, 2025
Downgrades: Neutral
Price Target: $25$14
Current: $14.95
Upside: -6.35%
Abbott Laboratories
Apr 17, 2025
Reiterates: Overweight
Price Target: $133$145
Current: $126.34
Upside: +14.77%
Maintains: Hold
Price Target: $20$21
Current: $18.64
Upside: +12.66%
Reiterates: Overweight
Price Target: $7$8
Current: $2.96
Upside: +170.27%
Maintains: Overweight
Price Target: $15$20
Current: $5.67
Upside: +252.73%
Maintains: Overweight
Price Target: $6$5
Current: $3.10
Upside: +61.29%
Upgrades: Overweight
Price Target: $10$18
Current: $1.32
Upside: +1,263.64%
Maintains: Overweight
Price Target: $104$99
Current: $54.44
Upside: +81.85%